Evidence map›Paper›PMID 39967748›Full record

ReviewEnergy & fuels : an American Chemical Society journal2025

Solvent-Free Catalytic Hydrotreatment of Lignin to Biobased Aromatics: Current Trends, Industrial Approach, and Future Perspectives.

Ramesh Kumar Chowdari, Parameswaram Ganji, Blaž Likozar

Abstract readReview
In one paragraph

Review in Energy & fuels : an American Chemical Society journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Ramesh Kumar ChowdariInstitute of Chemistry, University of Graz, Heinrichstrasse 28/II, 8010 Graz, Styria, Austria.ORCID https://orcid.org/0000-0002-7744-8028
Parameswaram GanjiDepartment of Catalysis and Chemical Reaction Engineering, National Institute of Chemistry, Hajdrihova Ulica 19, 1001 Ljubljana, Slovenia.ORCID https://orcid.org/0000-0003-4668-8923
Blaž LikozarDepartment of Catalysis and Chemical Reaction Engineering, National Institute of Chemistry, Hajdrihova Ulica 19, 1001 Ljubljana, Slovenia.ORCID https://orcid.org/0000-0001-7226-4302

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Lignin is the only naturally occurring, renewable biopolymer and an alternative for the production of six-membered aromatic chemicals. The utilization of lignin can increase the additional revenue of biorefineries and reduce the dependence on crude oil for the production of aromatic chemicals. Therefore, the development of technologies for the production of valuable chemicals from lignin waste in biorefineries is of great importance. Catalytic hydrotreatment of lignin is considered one of the most promising technologies for the production of biobased aromatic chemicals and fuels. Among the various hydrotreatment routes, the solvent-free hydrotreatment approach is advantageous because this process reduces production costs and is similar to petroleum refinery processes such as cracking and heteroatom removal. This review addresses recent developments in solvent-free catalytic hydrotreatment of various lignins such as sulfur-containing, sulfur-free, and pyrolytic lignins to produce low oxygen-containing aromatics such as alkylphenolics in batch, semicontinuous, and continuous reactors. Special emphasis is given to the various noble and non-noble metal catalysts, the best route between single and two-stage processing, key factors in solvent-free depolymerization of lignin, techno-economic evaluation, crude oil vs lignin oil refining, challenges and future prospects, etc.

Identifiers

PMID39967748
PMCPMC11831597

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.